Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

307.86
Delayed Data
As of 4:00pm ET
 +1.73 / +0.57%
Today’s Change
223.02
Today|||52-Week Range
333.65
+0.49%
Year-to-Date
Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review
Aug 24 / Zacks.com - Paid Partner Content
Ionis Pharmaceuticals Inc Begins to Shift Focus
Aug 16 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
Biogen and Ionis Pharmaceuticals climb on upbeat drug trials
Aug 01 / FT.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content